{"symbol":"LLY","provider":"yahoo-finance","fetchedAt":"2025-12-23T15:58:49.780Z","asOfDate":"2025-12-23","articles":[{"id":"7edd4556-2456-31da-bfbe-09e3723ed143","title":"Why Eli Lilly Shares Are Down On Tuesday","url":"https://finance.yahoo.com/news/why-eli-lilly-shares-down-152900646.html","publisher":"GuruFocus.com","publishedAt":"2025-12-23T15:29:00.000Z","relatedTickers":["NVO"],"mainIdea":"Why Eli Lilly Shares Are Down On Tuesday","summary":"GuruFocus.com: Why Eli Lilly Shares Are Down On Tuesday. Eli Lilly Faces Pressure as Novo's Daily Pill Hits the Market;' Related tickers mentioned: NVO."},{"id":"fac3133a-c4eb-3fdd-9a98-ff8bf67683d1","title":"Novo Nordisk Stock Sparks Massive Rally -- FDA Clears Wegovy Obesity Pill","url":"https://finance.yahoo.com/news/novo-nordisk-stock-jumps-fda-114848847.html","publisher":"GuruFocus.com","publishedAt":"2025-12-23T14:52:34.000Z","relatedTickers":["NONOF","NVO"],"mainIdea":"Novo Nordisk Stock Sparks Massive Rally -- FDA Clears Wegovy Obesity Pill","summary":"GuruFocus.com: Novo Nordisk Stock Sparks Massive Rally -- FDA Clears Wegovy Obesity Pill. FDA Decision Sparks Novo Stock Rally on Wegovy Pill Clearance Related tickers mentioned: NONOF, NVO."},{"id":"2e31d6b4-68b5-373b-8094-280dbed13228","title":"Novo's GLP-1 pill gets approved, Trump Media stock pulls back","url":"https://finance.yahoo.com/video/novos-glp-1-pill-gets-143905316.html","publisher":"Yahoo Finance Video","publishedAt":"2025-12-23T14:39:05.000Z","relatedTickers":["DJT","NONOF","NVO","QBTS"],"mainIdea":"Novo's GLP-1 pill gets approved, Trump Media stock pulls back","summary":"Yahoo Finance Video: Novo's GLP-1 pill gets approved, Trump Media stock pulls back. Yahoo Finance Executive Editor Brian Sozzi tracks some of Tuesday's trending tickers, including Novo Nordisk (NVO), Eli Lilly (LLY), D-Wave Quantum (QBTS), and Trump Media & Technology Group (DJT, DJTWW). To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief. Related tickers mentioned: DJT, NONOF, NVO, QBTS."},{"id":"690e6da6-9d98-3549-9fc1-298cfd6447f3","title":"Jim Cramer Says Eli Lilly’s GLP-1 Pill Is “Going to Revolutionize Everything”","url":"https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-051614791.html","publisher":"Insider Monkey","publishedAt":"2025-12-23T05:16:14.000Z","relatedTickers":["AMD","AVGO","CVX","MSFT","NVDA","SLG","TSM"],"mainIdea":"Jim Cramer Says Eli Lilly’s GLP-1 Pill Is “Going to Revolutionize Everything”","summary":"Insider Monkey: Jim Cramer Says Eli Lilly’s GLP-1 Pill Is “Going to Revolutionize Everything”. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer answered questions about. Inquiring if their portfolio is diversified, a caller highlighted that their top five holdings are LLY, SLG, MSFT, CVX, and TSM. Cramer said: “Really interesting setup here. Okay, so, Taiwan Semi is the actual fab that makes the chips for […] Related tickers mentioned: AMD, AVGO, CVX, MSFT, NVDA, SLG, TSM."},{"id":"8daff7dd-6122-3cb9-ad16-8a3df5fa8764","title":"Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug","url":"https://finance.yahoo.com/m/8daff7dd-6122-3cb9-ad16-8a3df5fa8764/novo-nordisk-jumps-as-fda-oks.html","publisher":"Investor's Business Daily","publishedAt":"2025-12-23T01:09:58.000Z","relatedTickers":["NONOF","NVO","VKTX"],"mainIdea":"Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug","summary":"Investor's Business Daily: Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug. The FDA approved Novo Nordisk's Wegovy pill as the first oral GLP-1 treatment for weight loss. The Danish drug giant jumped overnight. Related tickers mentioned: NONOF, NVO, VKTX."},{"id":"4c8488a3-403f-3c55-9b54-702e7df9bb01","title":"Pill Version of Wegovy Is Approved for Use in the U.S.","url":"https://finance.yahoo.com/m/4c8488a3-403f-3c55-9b54-702e7df9bb01/pill-version-of-wegovy-is.html","publisher":"The Wall Street Journal","publishedAt":"2025-12-22T23:38:00.000Z","relatedTickers":[],"mainIdea":"Pill Version of Wegovy Is Approved for Use in the U.S.","summary":"The Wall Street Journal: Pill Version of Wegovy Is Approved for Use in the U.S.. Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a month for the starting dose."}]}
